National Bank of Canada’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-248
Closed -$24.2K 2874
2025
Q3
$24.2K Buy
+248
New +$20K ﹤0.01% 2117
2024
Q4
Sell
-195
Closed -$20.4K 2911
2024
Q3
$20.4K Buy
195
+97
+99% +$11.3K ﹤0.01% 1935
2024
Q2
$13.8K Hold
98
﹤0.01% 2057
2024
Q1
$11.1K Buy
98
+71
+263% +$8.46K ﹤0.01% 2144
2023
Q4
$3.37K Sell
27
-48
-64% -$6.62K ﹤0.01% 2392
2023
Q3
$12.1K Sell
75
-66
-47% -$11.6K ﹤0.01% 2151
2023
Q2
$25.8K Hold
141
﹤0.01% 1948
2023
Q1
$18.8K Buy
+141
New +$16.6K ﹤0.01% 1986
2022
Q2
Sell
-236
Closed -$18K 2769
2022
Q1
$18K Buy
236
+214
+973% +$14.6K ﹤0.01% 2209
2021
Q4
$0 Buy
+22
New +$1.3K ﹤0.01% 2803

Other funds holding ACLS

National Bank of Canada's ACLS Position: Q4 2025 in Review

National Bank of Canada sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 248 shares — an estimated $24.2K sold.

National Bank of Canada first reported a position in ACLS in Q4 2021 and held it in 10 quarters. The position peaked at $25.8K in Q2 2023. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • National Bank of Canada reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • National Bank of Canada sold 248 Axcelis shares in Q4 2025, an estimated $24.2K.
  • National Bank of Canada first reported a position in Axcelis in Q4 2021 and held it in 10 quarters.
  • National Bank of Canada's Axcelis position peaked at $25.8K in Q2 2023.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.